Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in The Trade Desk Inc (Symbol: TTD), where a total volume of 32,889 contracts has been traded thus far today, a contract volume which is representative of approximately 3.3 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 51.4% of TTD's average daily trading volume over the past month, of 6.4 million shares. Especially high volume was seen for the $45 strike put option expiring August 19, 2022, with 2,258 contracts trading so far today, representing approximately 225,800 underlying shares of TTD. Below is a chart showing TTD's trailing twelve month trading history, with the $45 strike highlighted in orange:
Insulet Corp (Symbol: PODD) saw options trading volume of 2,148 contracts, representing approximately 214,800 underlying shares or approximately 50.8% of PODD's average daily trading volume over the past month, of 422,495 shares. Particularly high volume was seen for the $250 strike put option expiring August 19, 2022, with 667 contracts trading so far today, representing approximately 66,700 underlying shares of PODD. Below is a chart showing PODD's trailing twelve month trading history, with the $250 strike highlighted in orange:
And Axsome Therapeutics Inc (Symbol: AXSM) saw options trading volume of 4,114 contracts, representing approximately 411,400 underlying shares or approximately 50.8% of AXSM's average daily trading volume over the past month, of 809,550 shares. Especially high volume was seen for the $20 strike put option expiring August 19, 2022, with 1,003 contracts trading so far today, representing approximately 100,300 underlying shares of AXSM. Below is a chart showing AXSM's trailing twelve month trading history, with the $20 strike highlighted in orange:
For the various different available expirations for TTD options, PODD options, or AXSM options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
